The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHutchmed Share News (HCM)

Share Price Information for Hutchmed (HCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 310.00
Bid: 307.00
Ask: 312.00
Change: 0.00 (0.00%)
Spread: 5.00 (1.629%)
Open: 311.00
High: 314.00
Low: 303.00
Prev. Close: 310.00
HCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Arden Partners to return to annual profitability

Wed, 24th Mar 2021 16:44

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Arden Partners PLC - UK-based corporate adviser and multi-service stockbroker - Says trading since mid-February has remained strong, with all areas of the business performing well. In the current financial year to date, Arden Partners says it has completed seven secondary equity fundraisings, raising in excess of GBP75 million for its clients compared to GBP90 million raised in the whole of the previous financial year. Going forward, the company says market sentiment has remained positive and lower levels of volatility have created a favourable environment for the equities division. Arden Partners says it is focused on sustaining this positive momentum across the business and remains confident of returning to profitability this year.

----------

Property Franchise Group PLC - UK-based lettings and estate agency franchising firm - Completes the acquisition of Hunters Property PLC on Monday, says it is now the leading property franchise group in the UK, managing the second largest estate agency network and portfolio of lettings properties. Property Franchise notes 2020 was "a volatile year" for the estate and lettings agency industry as companies navigated an unprecedented period of full closure and various levels of restrictions for the remainder of the year. Network income increased to GBP94 million from GBP93 million in 2019, while revenue rose to GBP11.5 million from GBP11.4 million year-on-year. The company noted that the sales pipeline has continued at strong levels. As a result, at the end of February, the sales agreed pipeline had only reduced by 6% since the end of 2020, when they were at record highs. "Whilst the outlook for the UK economy remains difficult to predict, we are confident that an exciting year of progress is ahead of the group," the company says in its statement Wednesday.

----------

Bloomsbury Publishing PLC - London-based publishing house of fiction and non-fiction - Says revenue for the 12 months ending February 28 is expected to be ahead and profit significantly ahead of upgraded market expectations of GBP171.0 million and GBP14.8 million, respectively. For its financial 2020, Bloomsbury reported revenue of GBP162.8 million and pretax profit of GBP13.2 million. "We are confident, though, in the underlying strength of our business, the quality of our titles and content and our long-term strategy. Our medium and long-term expectations remain unchanged," says Chief Executive Nigel Newton. The company intends to report its full-year results in June.

----------

Rockfire Resources PLC - gold and base metal exploration company - Says a helicopter-supported aeromagnetic survey and a radiometric survey have commenced at its Copper Dome porphyry copper project in North Queensland, Australia. Rockfire says the helicopter arrived at the survey site, where the flight crew conducted a reconnaissance flight to check terrain, optimal flight altitudes, survey equipment registration and general orientation in the survey area. The survey is expected to commence on Thursday. "We expect the geophysical surveys to provide important information about faults and other structures which are not readily observable at surface," says Chief Executive David Price.

----------

Resolute Mining Ltd - Australian gold miner - Receives a letter from the Ghanaian Minerals Commission advising that, on the instructions of the Ghanaian Honourable Minister of Lands & Natural Resources, the mining lease for the Bibiani gold mine stands terminated. The company says it has been advised to cease all activities and operations at the mine site. "This action is unexpected and Resolute Mining is seeking clarification from the minister's office for the rationale for the termination. As a result of this notice Resolute Mining is currently seeking legal advice on the validity of the notice, its rights of appeal and potential recourse while considering the impact of the notice on the sale agreement with Chifeng Jilong Gold Mining Co Ltd for the sale of the Bibiani gold mine," the company says in its statement Wednesday.

----------

Cornish Metals Inc - Vancouver, Canada-based company which is building a portfolio of strategic metals assets in UK and North America - Says it will commence an exploration drilling programme at its United Downs project in Cornwall, UK, on April 6, after receiving confirmation of its permitted development rights. The aim of the drill programme is to follow-up on the discovery of high-grade copper-tin mineralisation in drill hole GWDD-002. Drilling will take place at up to five separate drill sites. "The first phase of the programme will focus on tracing the recently discovered high-grade copper-tin structure along strike and down to a depth of up to 500 metres. Thereafter, depending on success, we aim to conduct a second phase of infill drilling later in the year to enable a maiden mineral resource to be defined," says Chief Executive Richard Williams.

----------

TransGlobe Energy Corp - Calgary, Canada-based oil exploration and production company - Says the recompletion of SGZ-6X well in Egypt to the deeper, more prospective lower Bahariya reservoir has been concluded. The well commenced production on Sunday at a field-estimated production rate of 3,600 barrels of oil equivalent per day of light oil. On Monday, the well was restricted to a field-estimated 1,000 barrels of oil equivalent per day of light-oil on a reduced choke to facilitate reservoir data gathering and the preparation of an effective reservoir management plan for the lower Bahariya at this location. TransGlobe also said work to expand the early production facility at South Ghazalat has been completed. Elsewhere, the company says the EDC-64 rig has now rigged down at SGZ-6X and is mobilizing to the company's Eastern Desert concessions, also in Egypt, where operations on the budgeted twelve well 2021 drilling program are expected to commence in April.

----------

Echo Energy PLC - Latin American focused upstream oil and gas company - Confirms that, following an auction for industrial clients, it has secured two new gas sales contracts at significant premiums to both prevailing spot market rates and 2020 contracted rates. Echo Energy says the contracts have a term of 12 months, with gas sales beginning in May. "It is encouraging to now go further and see the improved market conditions translate to tangible improvements in future revenue. We believe that as a result of these agreements, our contracted gas US dollar revenues for the year could be as much as 50% higher when compared to May 2020 to April 2021, meaning they will deliver a material improvement in cashflow during 2021," says Chief Executive Martin Hull.

----------

Jangada Mines PLC - natural resources company - Says its investee ValOre Metals Corp reported assay results for three trenches and 19 Trado auger holes collected from the Santo Amaro South target area at Pedra Branca platinum group elements project in northeastern Brazil. ValOre says assay results validate Trado auger drilling as an effective exploration technique to confirm near-surface platinum group elements mineralization at Pedra Branca and advance targets to drill-ready stage. "We have just begun receiving encouraging assays from Trado auger drilling and mechanical trenching, which define a platinum group elements-mineralised trend 800 metres to the south of the Santo Amaro inferred resource," sys ValOre Chair & Chief Executive Jim Paterson. "Follow-up work will test continuity and extensions of the undrilled over 400 metres long platinum group elements-mineralized ultramafic belt at Santo Amaro South."

----------

Xtract Resources PLC - London-based metals and minerals producer - Says drilling on hole BRDD-21-006 recommenced at the Bushranger project in New South Wales, Australia, earlier than anticipated, as the adverse weather conditions on site relented. The hole has now advanced to 333 metres depth with continuing pyrite, pyrrhotite and traces of chalcopyrite, typical of the outer margin of the Racecourse porphyry system.

----------

Bahamas Petroleum Co PLC - Caribbean and Atlantic margin focused oil and gas company - Says it intends to renew the four southern licences in Bahamas into a third, three year "drill or drop" exploration period. The move follows discussions with industry counterparties in relation to a potential farm-out of Bahamas Petroleum Co's licences in Bahamas. Elsewhere, the company says formal contract execution for Off-1 block in Uruguay expected in the second quarter of 2021.

----------

Taseko Mines Ltd - Vancouver, Canada-based copper producer - Says a decision released by the Arizona Court of Appeals has confirmed all aspects of the Superior Court of Arizona's 2019 decision in favour of Florence Copper, rejecting every argument made by the Town of Florence's lawyers in their appeal of the lower court's ruling, upholding Florence Copper's right to mine its private property within the town, and confirmed the awarding of USD1.7 million in legal fees and costs to Florence Copper.

----------

Gunsynd PLC - UK-based investment firm - Says it has invested GBP125,000 in Anglo Saxony Mining Ltd, a tin development and exploration company. Gunsynd says it has subscribed for 833,333 shares at 15 pence each. Gunsynd's investment is a part of a of GBP5.0 million capital raising supported by institutional and high net worth UK, German and Australian investors. The company says funds will be used by Anglo Saxony for resource expansion drilling, resource conversion, metallurgical test work and per-feasibility study & optimisation studies.

----------

BMO Private Equity Trust PLC - UK-based investor - Says software company Dotmatics, in which it has a holding, has agreed for takeover by US-based Insightful Science. The transaction is expected to complete early in the second quarter. Taking both the co-investment and the holding through the fund together, the transaction values BMO Private Equity Trust's position at GBP37.7 million or 51p per share. This compares with the last published valuation as at the end of September 2020 of GBP9.5 million or 13p per share.

----------

Hutchison China Meditech Ltd - Hong Kong-based pharmaceutical company - Initiates a phase Ib/II study of surufatinib in combination with BeiGene's tislelizumab in patients with advanced solid tumors in the US and Europe. The company says the first patient was dosed on Tuesday. This trial is to explore potential synergistic activity of the novel, oral angio-immuno kinase inhibitor surufatinib with the anti-PD-1 antibody tislelizumab in enhancing overall antitumor activity from inhibition of angiogenesis along with stimulation of an immune response. This is an open-label study to evaluate the safety, tolerability, pharmacokinetics and efficacy of surufatinib in combination with tislelizumab in patients with advanced solid tumors. The study consists of two parts: dose finding and dose expansion. Hutchison China Meditech also says it has reached an agreement with GL Mountrose Investment Two Ltd, a company controlled and managed by GL Capital Group, to sell its entire indirect interest in Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Co Ltd, a non-core and non-consolidated over-the-counter drug joint venture business. Hutchison China Meditech to receiver USD169 million in cash. Of the proceeds, USD127 million is related to its shareholding in Hutchison Whampoa Guangzhou with the USD42 million balance related to distributions of land compensation and prior year undistributed profit. A deposit of USD15.9 million is payable by GL Capital immediately following signing of the agreement which will be credited against the proceeds due on closing of the transaction. The transaction is expected to close in mid-2021.

----------

Novacyt SA - Anglo-French biotechnology company - Says it will launch SNPsig VariPLEX this week as a CE-Mark approved polymerase chain reaction assay panel able to detect the four Covid-19 variants of concern that are currently recognised and the two most biologically significant mutations in a single kit. Concurrently, Novacyt says it is also making a research use only version of VariPLEX available for epidemiological application and will be pursuing emergency use authorisations in a number of countries.

----------

Arix Bioscience PLC - venture capital company focused on investing in biotech companies - Starts a strategy implementation review. Arix says the review will examine board composition, ensuring that its governance reflects best practice and has the right mix of skills and experience. It will also look into executive resourcing, choosing the right mix of skills and experience to deploy capital into the company's exciting pipeline of new opportunities. Finally, Arix says it will review remuneration structures, enabling it to attract and retain the right talent for the business. "We aim to report the review's initial findings in time for the 2021 annual general meeting and welcome constructive engagement from all those with whom we have a relationship, as we work to ensure Arix offers a high quality platform to identify and support exciting new biotech opportunities," says Chair Naseem Amin.

----------

BioPharma Credit PLC - UK-based investment company - Says it, through its fully owned subsidiary, together with BioPharma Credit Investments V (Master) LP has entered into a USD300 million definitive senior secured loan agreement with LumiraDx Investment Ltd and LumiraDx Group Ltd. BioPharma Credit says it will invest USD150 million and BioPharma-V will invest an additional USD150 million. The loan will mature in March 2024 and will bear interest at 8.0% per annum along with an additional consideration of 2.5% of the loan amount payable upon funding plus an additional 1.5% of the loan payable at maturity. The lenders will also be receiving warrants as part of the financing, BioPharma Credit notes.

----------

Immotion Group PLC - UK-based immersive entertainment firm - Says its 22-seat 'Undersea Explorer' theatre opened last weekend at Clearwater Marine Aquarium in Florida, US. Footfall at the aquarium was strong and the early uptake of the company's installation was "very encouraging".

----------

TP ICAP Group PLC - London-based provider of brokering services - Completes the acquisition of Liquidnet Holdings Inc. TP ICAP says the acquisition creates a diversified global markets infrastructure and data solutions provider, with the enlarged group well-positioned to benefit from market structure trends related to buyside objectives. The acquisition was first announced in October last year. The deal comprises an upfront consideration of USD525 million on the completion, and a deferred consideration of USD50 million. TC ICAP will pay up to a further USD125 million depending on the performance of the Liquidnet Equities business over the three-year period from the start of 2021.

----------

XLMedia PLC - digital performance publisher - Completes the acquisition of the business and assets of Sports Betting Dime. The website sportsbettingdime.com is now operating under XLMedia's existing licences and referring clients to its regulated US operator partners, under normal contractual terms. "We believe the combination of Sports Betting Dime and CBWG, which we acquired in December last year, provides the group with immediate scale and broad market reach at a time when US sports betting is experiencing significant growth momentum as additional states regulate and open up to legalised sports betting," says XLMedia Chief Executive Stuart Simms.

----------

Parkmead Group PLC - energy firm focused on growth through gas, oil and renewables projects - Completes two sales of two separate areas of non-core land from its UK renewable energy portfolio for GBP4.0 million. This divestment follows detailed analysis carried out across the company's onshore land portfolio, it says. Sites with the largest renewable energy potential have been retained and high-graded, with a strategy to divest non-core land. These sales are in line with this strategy. "The successful divestments of the non-core land are a testament to the team's ability to ensure value is derived from its portfolio of assets," says Executive Chair Tom Cross. "Our team continues to carefully evaluate further renewable energy acquisitions that will complement our gas and oil projects."

----------

STM Group PLC - financial services firm - Reports sale of its Gibraltar based trust and company services business and its tax compliance business for GBP2.5 million plus net assets upon completion of GBP570,000. The sale complements STM Group's strategy to focus on its core activities of pension administration and life assurance. The sale proceeds will be used to fund organic growth opportunities and further support the company's mergers & acquisitions strategy.

----------

Guild Esports PLC - London-based esports business - Reports the signing of Jannis Matwin as the fifth member of its pro Fortnite team. "We are excited to have JannisZ join Guild, which further strengthens our position as Europe's most dominant and decorated Fortnite team organisation," says Executive Chair Carleton Curtis. "He strengthens our already-formidable team, currently ranked number one in Europe, and we look forward to working with JannisZ to facilitate his growth as a player and build on his success to date."

----------

Microsaic Systems PLC - micro-engineering, miniaturised chip-based mass spectrometry developer - Signs a three-year, full technical and commercial agreement with DeepVerge PLC's subsidiary Innovenn UK Ltd. Microsaic says it will supply regulatory approved, CE mark, miniaturised mass spectrometry equipment and services on a non-exclusive basis across DeepVerge's global sales, marketing and distribution channels, delivering portable solutions for healthcare diagnostic evaluation and environmental contamination detection of samples. Microsaic says an initial order by DeepVerge was placed for three units, with a total value of GBP100,000, plus a commitment of up to GBP150,000 from DeepVerge for equipment and services to be installed at pilot facilities in DeepVerge's laboratories based in York.

----------

Fox Marble Holdings PLC - AIM listed company focused on marble quarrying and processing in Kosovo and the Balkans region - Signs a contrct to supply a major municipal construction project in Kosovo. The contract, valued in excess of EUR190,000, is to deliver cut and finished paving tiles for installation in the first stage of the redevelopment of the town square in Kamenica, eastern Kosovo. The 6,500 square metres of cut and finished paving tiles will be supplied over the course of 2021 using material from Fox Marble's quarries processed in its factory in Lipjan, Kosovo. This contract has been entered into with the developers charged with restoring the town square, which will be paved with material exclusively supplied by Fox Marble.

----------

Hargreaves Services PLC - AIM-listed company delivering services to the industrial and property sectors - Says its specialist earthworks business, Blackwell, has been appointed by the EKFB joint venture to carry out earthworks on part of the HS2 project. EKFB is a joint venture comprising Eiffage, Kier, Ferrovial Construction and BAM Nuttall which has been appointed by HS2 Ltd to complete the C2/C3 section of the HS2 phase 1 project. The appointment follows Blackwell's 2018 engagement by the EKFB team as an advance works contractor and falls on the ninth anniversary of Blackwell's association with the HS2 programme in a professional services capacity. The subcontract appointment is for 30 kilometres of the HS2 earthworks centred on Aylesbury in Buckinghamshire and involves the movement of nearly 15 million cubic meters of chalk and clay over the next four years.

----------

Surface Transforms PLC - manufacturer of carbon fibre reinforced ceramic automotive brake discs - Agrees on a GBP1 million flexible growth fund loan from Liverpool City Region Combined Authority. The loan, which is administered by the Merseyside Special Investment Fund, is tied to capital expenditure and will be drawn down between March 29 and September 29, the company explains. The loan carries interest at 2.0% over Bank of England base rate and is repayable over five years in equal monthly instalments following a three-month repayment holiday.

----------

SIMEC Atlantis Energy Ltd - developer of renewable and sustainable energy projects - Notes the decision by the Welsh Government to "call in" its planning application. SIMEC says it will work closely with Welsh Government to understand the next steps. Planning permission is sought for the construction of new silos, conveyors, and rail upgrade for handling the new fuel external to the existing Uskmouth power station and not for the conversion of the power station itself. The Uskmouth project contributes to the delivery of sustainable development by reusing existing resources and the reduction in waste to landfill, while also creating jobs and bringing investment to the region.

----------

Conduity Capital PLC - cash shell - Says it was in discussions with a number of different businesses regarding the potential acquisition, However, after recent discussions with the company's broker, Peterhouse Capital, it has decided to explore the raising of additional funds to enable the company to become an investing company quoted on AIM. Conduity Capital says it will not be in a position to complete the acquisition or raise from investors at least GBP6 million by the time the six-months term of it becoming a cash shell expires. As such, the London Stock Exchange is expected to suspend trading in the company's shares, pursuant to rule 15, on April 6.

----------

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
29 Aug 2023 09:30

IN BRIEF: China grants Hutchmed's savolitinib breakthrough therapy tag

Hutchmed (China) Ltd - Hong Kong-based developer of treatments for cancer and immunological diseases - Wins 'breakthrough therapy designation' in China for its gastric cancer treatment, savolitinib. The BTD is granted by the National Medical Products Administration. It is for the treatment of locally advanced or metastatic gastric cancer or gastroesophageal junction adenocarcinoma patients with mesenchymal epithelial transition factor amplification who have failed at least two lines of standard therapies. Hutchmed notes that MET-driven gastric cancer has a poor prognosis, and China grants a BTD to new drugs that treat life-threatening diseases for which there are no effective treatment options.

Read more
21 Aug 2023 08:46

Hutchmed China hails trial on sovleplenib meeting primary endpoint

(Alliance News) - Hutchmed (China) Ltd on Monday said a phase 3 trial evaluating the investigational use of sovleplenib met its primary endpoint.

Read more
21 Aug 2023 08:24

Hutchmed meets all endpoints in platelet disorder treatment trial

(Sharecast News) - Hutchmed China reported a breakthrough from its recent phase three trial in sovleplenib on Monday, reporting that it met its primary endpoint and all secondary endpoints for treating adult patients with primary immune thrombocytopenia - a platelet disorder - (ITP) in China.

Read more
31 Jul 2023 12:47

Hutchmed swings to profit after "sharpening goals and priorities"

(Alliance News) - Hutchmed (China) Ltd on Monday reported sharp first-half revenue growth, as a strategy change to boost its fortunes outside of China saw early fruit.

Read more
24 Jul 2023 15:46

UK earnings, trading statements calendar - next 7 days

Tuesday 25 July 
City of London Investment Group PLCTrading Statement
Compass Group PLCTrading Statement
Croda International PLCHalf Year Results
Games Workshop Group PLCFull Year Results
Greencore Group PLCTrading Statement
Hummingbird Resources PLCTrading Statement
MITIE Group PLCTrading Statement
Paragon Banking Group PLCTrading Statement
Reach PLCHalf Year Results
Smart Metering Systems PLCTrading Statement
Tristel PLCTrading Statement
Tyman PLCHalf Year Results
Unilever PLCHalf Year Results
Unite Group PLCHalf Year Results
Wednesday 26 July 
Aptitude Software Group PLCHalf Year Results
Breedon Group PLCHalf Year Results
Conduit Holdings LtdHalf Year Results
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
FRP Advisory Group PLCFull Year Results
Gresham Technologies PLCHalf Year Results
Lloyds Banking Group PLCHalf Year Results
Marston's PLCTrading Statement
Nichols PLCHalf Year Results
Primary Health Properties PLCHalf Year Results
Rathbones Group PLCHalf Year Results
Revolution Bars Group PLCTrading Statement
Rio Tinto PLCHalf Year Results
Science Group PLCHalf Year Results
Van Elle Holdings PLCFull Year Results
Thursday 27 July 
Allianz Technology Trust PLCHalf Year Results
Antofagasta PLCHalf Year Results
Capital & Regional PLCHalf Year Results
Card Factory PLCTrading Statement
Checkit PLCTrading Statement
Drax Group PLCHalf Year Results
Deliveroo PLCHalf Year Results
Derwent London PLCHalf Year Results
Entain PLCHalf Year Results
Greencoat UK Wind PLCHalf Year Results
Global Connectivity PLCHalf Year Results
Hostelworld Group PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Lancashire Holdings LtdHalf Year Results
Mitchells & Butlers PLCTrading Statement
OSB Group PLCHalf Year Results
Persimmon PLCHalf Year Results
Petrofac LtdHalf Year Results
Redcentric PLCFull Year Results
S&U PLCTrading Statement
Savills PLCHalf Year Results
Secure Trust Bank PLCHalf Year Results
Spirax-Sarco Engineering PLCHalf Year Results
Videndum PLCHalf Year Results
Wheaton Precious Metals CorpHalf Year Results
Friday 28 July 
AIB Group PLCHalf Year Results
GCP Infrastructure Investments LtdTrading Statement
International Consolidated Airlines Group SAHalf Year Results
Intertek Group PLCHalf Year Results
Jardine Matheson Holdings LtdHalf Year Results
NatWest Group PLCHalf Year Results
PayPoint PLCFull Year Results
PayPoint PLCTrading Statement
Standard Chartered PLCHalf Year Results
YouGov PLCTrading Statement
Monday 31 July 
Hutchmed (China) LtdHalf Year Results
Pearson PLCHalf Year Results
Pod Point Group Holdings PLCHalf Year Results
Quartix Technologies PLCHalf Year Results
Spectris PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
20 Jul 2023 14:14

IN BRIEF: Hutchmed progresses fruquintinib designation and testing

Hutchmed (China) Ltd - Hong Kong-based developer of treatments for cancer and immunological diseases - Granted breakthrough therapy designation, by the Center for Drug Evaluation of China's National Medical Products Administration, for oral inhibitor fruquintinib combined with PD-1 antibody sintilimab. BTD is for treatment of patients with previously treated advanced endometrial cancer.

Read more
10 Jul 2023 12:58

Hutchmed launches new phase one study in China

(Sharecast News) - Biopharmaceutical company Hutchmed China announced the launch of a phase one study in China for HMPL-415 on Monday - an investigational selective allosteric inhibitor that targeted Src homology-2 domain-containing protein tyrosine phosphatase-2 (SHP2).

Read more
10 Jul 2023 08:53

IN BRIEF: Hutchmed starts study for tumour treatment in China

Hutchmed (China) Ltd - Hong Kong-based cancer and immunological diseases' treatment developer - Starts phase one study in China of its SHP2 inhibitor HMPL-415 for the treatment of advanced malignant solid tumours. First patient received their first dose on Thursday last week. Hutchmed expects up to 80 patients to take part in the study. SHP2 is a non-receptor protein tyrosine phosphatase which controls cell growth and cell migration.

Read more
16 Jun 2023 08:51

Hutchmed, Takeda Fresco-2 study published in The Lancet

(Alliance News) - Hutchmed (China) Ltd on Friday said phase three results for its Fresco-2 study evaluating fruquintinib in patients with previously treated metastatic colorectal cancer, conducted alongside Takeda Pharmaceutical Co Ltd, were published in peer-reviewed journal, The Lancet.

Read more
16 Jun 2023 08:44

Hutchmed China's colorectal cancer study to be published

(Sharecast News) - Hutchmed China, alongside its partner Takeda, announced the publication of the phase three 'FRESCO-2' study results evaluating the use of fruquintinib in patients with previously-treated metastatic colorectal cancer (CRC) on Friday, in the Lancet medical journal.

Read more
15 Jun 2023 16:51

IN BRIEF: Hutchmed and Takeda get Europe marketing backing for drug

Hutchmed (China) Ltd - Hong Kong-based cancer and immunological diseases treatment developer - Says marketing authorisation application for fruquintinib, made alongside Tokyo-based Takeda Pharmaceutical Co Ltd, has been validated and caccepted by the European Medicines Agency. Fruquintinib is an inhibitor of vascular endothelial growth factor receptors used to treat cancers.

Read more
26 May 2023 13:13

US FDA gives priority to Hutchmed's colorectal cancer treatment

(Sharecast News) - Hutchmed China, in collaboration with Takeda, announced on Friday that the US Food and Drug Administration (FDA) has granted priority review for the New Drug Application (NDA) of fruquintinib.

Read more
26 May 2023 08:56

Hutchmed China celebrates FDA review, teases new data at ASCO meeting

(Alliance News) - Hutchmed China Ltd on Friday celebrated a priority review granted by the US FDA for its cancer drug fruquintinib, and promised to present new data for this and two other therapies at the American Society of Clinical Oncology next month.

Read more
5 May 2023 15:57

UK shareholder meetings calendar - next 7 days

Monday 8 May 
no events scheduled 
Tuesday 9 May 
Caledonia Mining Corp PLCAGM
Direct Line Insurance Group PLCAGM
Foxtons Group PLCAGM
Hostelworld Group PLCAGM
IWG PLCAGM
Just Group PLCAGM
Midwich Group PLCAGM
Osirium Technologies PLCAGM
Windward LtdAGM
Wednesday 10 May 
abrdn PLCAGM
Antofagasta PLCAGM
Cenkos Securities PLCAGM
Ecora Resources PLCAGM
H&T Group PLCAGM
Harbour Energy PLCAGM
Jupiter Fund Management PLCAGM
Literacy Capital PLCAGM
Luceco PLCAGM
Marshalls PLCAGM
National Express Group PLCAGM
Renewables Infrastructure Group LtdAGM
Rentokil Initial PLCAGM
Seplat Energy PLCAGM
Spirax-Sarco Engineering PLCAGM
TClarke PLCAGM
Thursday 11 May 
88 Energy LtdAGM
Cairn Homes PLCAGM
Capita PLCAGM
Clarkson PLCAGM
Costain Group PLCAGM
Eleco PLCAGM
Eurocell PLCAGM
FBD Holdings PLCAGM
Genedrive PLCGM re Equity Prepayment Facility
Genel Energy PLCAGM
Gresham House PLCAGM
Gym Group PLCAGM
Hiscox LtdAGM
Irish Continental Group PLCAGM
John Wood Group PLCAGM
MyHealthChecked PLCAGM
OSB Group PLCAGM
Poolbeg Pharma PLCAGM
Rolls-Royce Holdings PLCAGM
Serinus Energy PLCAGM
Uniphar PLCAGM
Videndum PLCAGM
WAG Payment Solutions PLCAGM
Friday 12 May 
Balfour Beatty PLCAGM
Derwent London PLCAGM
Goodbody Health LtdAGM
GreenRoc Mining PLCAGM
Hutchmed (China) LtdAGM
Itim Group PLCAGM
Itsarm PLCGM re delisting from AIM
Wheaton Precious Metals CorpAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
18 Apr 2023 12:30

Hutchmed's gastric cancer treatment accepted for review in China

(Sharecast News) - Hutchmed China announced on Tuesday that its new drug application (NDA) for fruquintinib, in combination with paclitaxel has been accepted for review by the National Medical Products Administration (NMPA) in China.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.